HEREDITARY CANCER CONSULTATION SERVICES

Similar documents
BRCA1 & BRCA2 GeneHealth UK

GeneHealth BRCA 1&2_ qxp_Layout 1 21/02/ :44 Page 3 BRCA1 & BRCA2 GeneHealth UK

Because Knowledge is a Powerful Tool. Focused on Patients

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

GeneHealth BreastGene_New qxp_Layout 1 21/02/ :42 Page 3 BreastGene GeneHealth UK

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS?

Hereditary Cancer Risk Testing: What to Expect

Genetic testing for hereditary cancer. An overview for healthcare providers

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

The Next Generation of Hereditary Cancer Testing

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

Advice about familial aspects of breast cancer and epithelial ovarian cancer

ProstateGene GeneHealth UK

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Clinical options for mutations of BRCA 1/2 genes. Ioannis Th. Natsiopoulos Breast surgeon

BRCAnowTM It s Your Decision

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Ovarian Cancer Causes, Risk Factors, and Prevention

Cancer Institute. cancer institute Program overview Report 2013

ProstateGene What is hereditary prostate cancer? What are genes?

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

Information for You and Your Family

PROVIDER POLICIES & PROCEDURES

Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017

Genetic Determinants, Risk Assessment and Management

Patient Information Form

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

HBOC. Jessica M. Salamone, ScM, CGC

I have ovarian cancer

What You Need to Know About Ovarian Cancer

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

BRCAplus. genetic testing for hereditary breast cancer

Genetic Testing: who, what, why?

Are you at risk of Hereditary Cancer? Your Guide to the Answers

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

12: BOWEL CANCER IN FAMILIES

Does Cancer Run in Your Family?

Hereditary Colorectal Cancer

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

Why Test for Hereditary Cancer in Preventive Care?

Welcome! Here s our agenda for today:

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

Tumori eredofamiliari: sorveglianza di donne ad alto rischio

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Multigene Panel Testing for Hereditary Cancer Risk

Oncology 101. Cancer Basics

What All of Us Should Know About Cancer and Genetics

I have ovarian cancer

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

Please read the following instructions carefully

Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

Cancer Risk Assessment Questionnaire

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

Cancer Genomics 101. BCCCP 2015 Annual Meeting

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Approximately 5% to 10% of breast cancer (BC) is hereditary in nature. Since. By Dawna Gilchrist, MD, FRCPC, FCCMG

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Lori Carpenter, MS, LCGC Saint Francis Hospital

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

Genetic Risk Assessment for Cancer

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

CANCER GENETICS PROVIDER SURVEY

Outline. Identifying your risk for hereditary breast or ovarian cancer. Genetics 101. What causes cancer? Genetics

Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC

Clinical Genetics Service

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

Learn your genetic risk for the most common hereditary cancers.

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

Genetic Risk Assessment for Cancer

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

Welcome to the Winship Cancer Institute Genetic Counseling Program

Clinical Genetics Service

We know that treatments are now targeting genes, but does genetics play a bigger role in cancer outside of that?

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention

BRCA1 & BRCA2: CANCER RISK & GENETIC TESTING IAP ID 2013 NAIR HOSPITAL, MUMBAI

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 15, 1997 October 9, 2013

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

YES. If yes, indicate what types of tumors/polyps and age of onset:

Transcription:

In cooperation with HEREDITARY CANCER CONSULTATION SERVICES Risk assessment, genetic counseling and genetic testing for hereditary cancer syndromes INTERNAL MEDICINE SPECIALTY CLINIC COMPETENCE FOR YOUR HEALTH

Dear Patient, in some cases cancer diseases seem to run like a golden tread in families. This is, in particular, the case for colorectal or breast and ovarian cancer. Familial clustering of cancer can be caused by a genetic disposition which is passed from one generation to the next. COLORECTAL CARCINOMA Colorectal cancer is one of the most frequent cancer diseases worldwide. The majority of cases arise at an advanced age and as a single case in a given family. In about one quarter of the cases there is familial clustering of the disease which may indicate an inherited form. BREAST AND OVARIAN CANCER About one in 10 women in developed countries develops breast cancer. In about one third of the cases familial clustering can be observed, and in up to 10% of all cases a genetic defect in a single gene (such as BRCA1 or BRCA2) is causing the disease. In the case of ovarian cancer, it is believed that about 15% occur because of a genetic mutation. Such a genetic defect can also increase the risk for developing pancreatic or prostate cancer. 5% to 10% of all cancer diseases is inherited and caused by mutations in single genes that contribute to the development of a particular type of cancer. People carrying such a mutation have a significantly increased risk for this type of cancer. Appointments for the Hereditary Cancer Consultation Services can be made at our clinic in Herrsching (Ammersee) or at the MVZ for Molecular Diagnostics in Munich [outpatient healthcare centre]. You will find contact details on the last page. OTHER CANCER DISEASES Genetic factors can also play a role for the development of other cancer diseases. Examples include pancreatic cancer, skin cancer, uterine cancer or gastric cancer. For many inherited cancer diseases, a genetic predisposition can be identified prior to disease onset by genetic testing. When a genetic mutation is identified, specific measures for the prevention and early detection of cancer can be initiated. In patients already affected by cancer, detection of a mutation can guide treatment options for optimized patient management.

CHARACTERISTICS OF CANCER PREDISPOSITION SYN- DROMES Familial occurrence of a particular type of cancer, younger-than-usual age of onset as well as rare types of cancer are characteristic features of an inherited predisposition for cancer. In order to assess your own risk for a hereditary cancer syndrome, please check if one or more of the following statements apply to you and/or your family: Multiple cancer diseases in the same branch of the family either on your mother s or father s side Young age of onset Cancer below the age of 50 2 or more cases of: Cancer of the colon, uterus, ovary, stomach cancer, cancer of the pancreas and or any other kind of cancer disease Breast, ovarian, prostate and/or pancreatic cancer Skin and/or pancreatic cancer Colon cancer Breast cancer Uterine cancer Age Number HEREDITARY CANCER RISK CONSULTATION To determine if a patient has a genetic predisposition for cancer, we have established a multidisciplinary consultation service for hereditary cancer in cooperation with the MVZ for Molecular Diagnostics in Munich. This consultation service provides genetic counseling of cancer patients as well as asymptomatic individuals at risk and a detailed analysis of their personal and family history. It is often possible to address many of your concerns during the initial consultation. If the consultation actually indicates a predisposition for cancer, possible further steps will be discussed with you. Rare cancer diseases in the family Ovarian cancer Breast cancer in men or triple-negative breast cancer Certain forms of ovarian cancer Certain forms of colon cancer Type Other factors 10 or more intestinal polyps If one or more of the statements is true, a detailed assessment is recommended. Please feel free to contact us.

GENETIC COUNSELING During a genetic counseling appointment, we will first assess if there is a susceptibility for cancer in your family. To address this question we need to know who in your family has developed what type of cancer at what age. We will take a detailed family history, and we will evaluate and analyze your personal and family history of cancer. Any information resulting from this analysis will be explained to you in detail. GENETIC ANALYSIS Once you have decided in favour of a genetic test, this can be performed directly at the clinic. For the analysis, we only require a blood sample which is taken either at the clinic or at the MVZ in Munich. The genetic test enables us to identify genetic changes (so-called mutations) in certain genes which are associated with an increased risk for the development of cancer. The genes are analyzed with state-of-the-art modern technology developed for the detection of mutations. It takes about 14 days to perform the molecular genetic test. The result as well as the consequences for you or your relatives are discussed with you in a further genetic counseling session. Based on the test results we will develop an individualized management plan with you aimed at the early detection or optimized treatment of disease according to your specific needs. You will then be informed of the possible diagnostic options. We will discuss with you whether a genetic test is useful in your case, providing you with the pros and cons of such an examination. After taking sufficient time for consideration you have the opportunity to discuss further questions for an informed decision about genetic testing. If a mutation is identified in your DNA which is associated with an increased risk for cancer, we will provide you with various medical options, e. g. regular screening for the early detecting of cancer and treatments to reduce the occurrence of cancer. This will reduce your risk and improve your prognosis. Since the knowledge of an increased risk for cancer can be a distressing experience, we will offer you support for your care across numerous specialties and the opportunity to discuss your conditions with us at any time.

CONTACT Privatklinik Dr. Robert Schindlbeck Seestrasse 43 82211 Herrsching am Ammersee Mrs Monika Waibel Phone +49 8152 29-258 Fax +49 8152 29-158 info@klinik-schindlbeck.de www.klinik-schindlbeck.de Appointments: Mon Thu 9:00 a.m. 5:00 p.m. Fri 9:00 a.m. 12:00 noon HOW TO REACH US: By car: Travel from Munich via the motorway A95 Munich Lindau, exit Oberpfaffenhofen; then travel in the direction of Herrsching (15 km) Train: Take the S-Bahn (commuter train) Line S8 in the direction of Herrsching) (terminus), distance to the clinic approx. 200 m. A taxi stand is located in front of the train station. MVZ für MolekularDiagnostik Candidplatz 13 81543 Munich Mrs Jessica Hänßler Phone +49 89 809 115-780 Fax +49 89 809 115-790 info@mvzmolekulardiagnostik.de www.mvzmolekulardiagnostik.de Appointments: Mon Thu 8:00 a.m. 4:00 p.m. Fri 8:00 a.m. 1:00 p.m. HOW TO REACH US: By car: Basement garage Ärztehaus Candidplatz, parking area for visitors Waldeckstraße, P&R Schönstraße Bus: Line 52, stop Candidplatz U-Bahn [underground]: Line 1, stop Candidplatz Tram: Line 15 and 25, stop Tegernseer Landstraße or Wettersteinplatz If possible, please bring all of your written medical reports with you, also those of your relatives who have documented cancer diseases on the date of your consultation. For German patients, the costs for genetic counseling and genetic testing are covered by the national health insurance funds. Please bring your health insurance card with you or a letter of referral to your consultation appointment. If you are a private patient costs will be billed according to the medical fee schedule [Gebührenordnung für Ärzte] (GOÄ).